USO DE PROBIÓTICOS NA PRÁTICA CLÍNICA DO TRANSTORNO DO ESPECTRO AUTISTA
DOI:
https://doi.org/10.47820/recima21.v3i6.1553Palavras-chave:
Probióticos, Transtorno do Espectro Autista, Microbiota GastrointestinalResumo
Objetivo: caracterizar os estudos relacionados ao uso de probióticos na prática clínica do transtorno do espectro autista. Métodos: trata-se de uma pesquisa exploratória e descritiva, sob forma de revisão integrativa, onde foram incluídos artigos originais realizados com indivíduos com diagnóstico de autismo que utilizavam probióticos, em um recorte temporal de dez anos (2009 a 2019). Resultados: as cepas probióticas utilizadas no autismo mais descritas nos estudos foram do gênero Lactobacillus (77,7%), Bifidobacterium (55,5%) e Streptococcus (33,3%). Foram relatadas melhoras em distúrbios comportamentais, cognitivos e gastrointestinais, assim como perda de sobrepeso e diminuição de marcadores inflamatórios. Os efeitos adversos de maior ocorrência foram diarreia (44,4%), constipação (22,2%), erupção cutânea (22,2%). Conclusão: Os estudos demonstraram associação benéfica com o uso de probióticos em crianças e jovens com autismo. A população dos estudos foi considerada pequena pelos autores, o que leva a proposta de ensaios clínicos controlados por placebo, com populações maiores, para obtenção de dados mais confiáveis.
Downloads
Referências
Kaluzna JC, Blaszczyk S. The level of arabinitol in autistic children after probiotic therapy. Nutrition. 2012;28(2):124-126.
Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun. 2012;26(3):383-392.
Ferguson BJ, Dovgan K, Takahashi N, Beversdorf DQ. The Relationship Among Gastrointestinal Symptoms, Problem Behaviors, and Internalizing Symptoms in Children and Adolescents With Autism Spectrum Disorder. Front Psychiatry. 2019;10(194)1-7.
Organização Pan-Americana de Saúde. Folha informativa - Transtorno do espectro autista. Disponível em: < https://www.paho.org/bra/index.php?Itemid=1098.> [acesso em 28 nov 2019].
Borre YE, Moloney RD, Clarke G, Dinan TG, Cryan JF. The impact of microbiota on brain and behavior: mechanisms and therapeutic potential. Avd Exp Med Biol. 2014;817(1):373-403.
Davignon MN, Qian Y, Massolo M, Croen LA. Psychiatric and Medical Conditions in Transition-Aged Individuals With ASD. Pediatrics. 2018;141(4):335-345.
Chaidez V, Hansen RL, Hertz-Picciotto I. Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord. 2014;44(5):1117–1127.
Baghdadli A, Pascal C, Grisi S, Aussilloux C. Risk factors for self-injurious behaviours among 222 young children with autistic disorders. J Intellect Disabil Res. 2003;47(8):622–7.
De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. Plos on. 2018;8(10)1-18.
Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D. Gastrointestinal microbiota in children with autism in Slovakia. Physiology & Behavior. 2015;138(1):179–187.
Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014;146(6):1500-1512.
De Magistris L, Siniscalco D, Bravaccio C, Loguercio C. Gut–Brain Axis: A New Revolution to Understand the Pathogenesis of Autism and Other Severe Neurological Diseases. Human Nutrition from the Gastroenterologist’s Perspective. 2016;10(4):49-65.
De Filippis M, Wagner KD. Treatment of Autism Spectrum Disorder in Children and Adolescents. Psychopharmacol Bull. 2016;46(2):18–41.
Brasil. Portaria n. 324, de 31 de março de 2016. Aprova o Protocolo Clínico e Diretrizes Terapêuticas do Comportamento Agressivo como Transtorno do Espectro do Autismo. Ministério da Saúde. 31 de mar de 2016.
Shanchack KE, Thomas CA. Autism Spectrum Disorder: Primary Care Principles. Am Fam Physician. 2016;94(12):972-979.
Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, Pollard EL, Roux S, Sadowsky MJ, Lipson KS, Sullivan MB, Caporaso JG, Krajmalnik-Brown R. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5(1):10-25.
Frye RE, Slattery J, MacFabe DF, Allen-Vercoe E, Parker W, Rodakis J, Adams JB, Krajmalnik-Brown R, Bolte E, Kahler S, Jennings J, James J, Cerniglia CE, Midtvedt T. Approaches to studying and manipulating the enteric microbiome to improve autism symptoms. Microb Ecol Health Dis. 2015;26(2):64-78.
Mayer EA, Padua D, Tillisch K. Altered brain-gut axis in autism: Comorbidity or causative mechanisms?. BioEssays. 2014;36(10):933–939.
Arnold EL, Luna RA, Williams K, Chan J, Parker R, Wu Q, Hollway JA, Jeffs A, Lu F, Coury DL, Hayes C, Savidge T. Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot Trial. Journal of Child and Adolescent Psychopharmacology. 2019;20(20):1-11.
Bonavina L, Arini A, Ficano L, Jannuzziello D, Pasquale L, Aragona SE, Ciprandi G. Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders. Acta Biomed. 2019;90(7):8-12.
Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D. Nejdi A, Bisson J, Rougeot C, Pichelin M, Cazaubiel M, Cazaubiel J. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105(5):755-764.
Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, Logan AC. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009;1(6):1-6.
. Kim YK, Shin C. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments. Curr Neuropharmacol. 2018;16(5):559-573.
Zhao L, Xiong Q, Stary CM, Mahgoub OK, Ye Y, Gu L, Xiong X, Zhu S. Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke. J Neuroinflammation. 2018;15(1):339-349.
Zhu X, Han Y, Du J, Liu R, Jin K, Yi W. Microbiota-gut-brain axis and the central nervous system. Oncotarget. 2017;8(32):53829-53838.
Botelho LR, Cunha CC, Macedo M. O método da revisão integrativa nos estudos organizacionais. Gestão e Sociedade. 2011;5(11):121-136.
Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. J Clin Epidemiol. 2009;62(10):1006-12.
West R, Roberts E, Sichel LS, Sichel J. Improvements in Gastrointestinal Symptoms among Children with Autism Spectrum Disorder Recceiving the Delpro® Probiotic and Immunomodulator Formulation. Probiotics and Health. 2013;1(102):1-6.
Grossi E, Melli S, Dunca D, Terruzzi V. Unexpected improvement in core autism spectrum disorder symptoms after long-term treatment with probiotics. SAGE Open Medical Case Reports. 2016;4(1):1–5.
Parracho HMR, Gibson GR, Knott F, Bosscher D, Kleerebezem M, McCartney AL. A Double-blind, Placebo-controlled, crossover-designed Probiotic Feeding Study in Children Diagnosed With Autistic Spectrum Disorders. International Journal of Probiotics and Prebiotics. 2010;5(2):69-74.
Shaaban SY, El Gendy, Mehanna NS, El-Senousy WM, El-Feki HS, Saad K, El-Asheer OM. The role of probiotics in children with autism spectrum disorder: A prospective, open-label study. Nutritional Neuroscience. 2017;21(9):676-681.
Liu YW, Liong MT, Chung YE, Huang HY, Peng WS, Cheng Y, Lin Y, Wu Y, Tsai Y. Effects of Lactobacillus plantarum PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2019;1(4):820-835.
Russo AJ, Decreased Plasma Myeloperoxidase Associated with Probiotic Therapy in Autistic Children. Clinical Medicine Insights: Pediatrics. 2015;9(1):13–17.
Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2(94)1-15.
Gerard F. Gut microbiota and obesity. Cell Mol Life Sci 2016; 73(1):147–162.
Knip M, Siljander H The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol 2016; 12(3):154–167.
Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet M, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK. Gut microbiota regulare motor deficits and neuroinflammation in a model of parkinson's disease. Cell. 2016; 1;167(6):1469-1480
Collins SM1, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012;10(11):735-742.
Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011;11(22): 1-13.
Hammami R, Fernandez B, Lacroix C, Fliss I. Anti-infective properties of bacteriocins: an update. CMLS. 2013;70(16):2947–2967.
Williams BL, Hornig M, Buie T, Bauman ML, Cho Paik M, Wick I, et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One. 2011;6(9):1-21.
Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16(4):444-453.
El-Ansary AK, Ben Bacha A, Kotb M. Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflammation. 2012;9(74):1-14.
Abdelli LS, Samsam A, Naser SA. Propionic Acid Induces Gliosis and Neuro-inflammation through Modulation of PTEN/AKT Pathway in Autism Spectrum Disorder. Scientific Reports. 2019;9(8824):1-12.
Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta Pediatr. 2005;94(4):386-393.
Esnafoglu E, Cırrık S, Ayyıldız SN, Erdil A, Ertürk EY, Daglı A, Noyan T. Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects. J Pediatr. 2017;1(188):240-244.
PusponegoroHD, Ismael S, Sastroasmoro S, Firmansyah A, Vandenplas Y. Maladaptive behavior and gastrointestinal disorders in children with autism spectrum disorder. Pediatr Gastroenterol Hepatol Nutr. 2015;18(4):230–237.
Pärtty A, Kalliomäki M, Wacklin P, Salminen S, Isolauri E. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res. 2015;77(6):823-828.
Gronlund M, Arvilommi H, Kero P, Lehtonen O,Isolauri E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child Fetal Neonatal. 2000;83(3):186–192.
Million M, Angelakis E, Paul M, Armougom F, Leibovici L, Raoult D. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog. 2012;53(2):100-108.
Sharafedtinov KK, Plotnikova OA, Alexeeva RI, Sentsova TB, Songisepp E, Stsepetova J, Smidt I, Mikelsaar M. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients--a randomized double-blind placebo-controlled pilot study. Nutr J. 2013;12(138)1-11.
Zheng Z, Zhang L, Shiping L, Zhao f, Wang Y, Huang L, Huang J, Zou R, Qu Y, Mu D. Association among obesity, overweight and autism spectrum disorder: a systematic review and meta-analysis. Scientific Reports. 2017;7(11697)1-9.
Matheson BE, Douglas JM. Overweight and obesity in children with autism spectrum disorder (ASD): A critical review investigating the etiology, development, and maintenance of this relationship. Journal of Autism and Developmental Disorders. 2017;4(67):142-156.
Wu N, Chen Y, Yang J, Li F. Childhood Obesity and Academic Performance: The Role of Working Memory. Front Psychol. 2017;8(611)1-7.
McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014;133(5):872–883.
Santocchi E, Guiducci L, Fulceri F, Billeci L, Buzzigoli E, Apicella F, Calderoni S, Grossi E, Morales MA, Muratori F. Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters, a study protocol. BMC Psychiatry. 2016;16(183):1-16.
Szkaradkiewicz AK, Stopa J, Karpiński TM. Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz). 2014;62(6):495-500.
Milajerdi A, Mousavi SM, Sadeghi A, Salari-Moghaddam A, Parohan M, Larijani B, Esmaillzadeh A. The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. Eur J Nutr. 2019;8(931):1-17.
Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J. Appl. Microbiol. 2012;113(2):411-417.
Ng QX, Peters C, Ho CYX, Lim DY, Yeo WS. A meta-analysis of the use of probiotics to alleviate depressive symptoms. J Affect Disord. 2018;3(228):13-19.
Takada M, Nishida K, Kataoka-Kato A, Gondo Y, Ishikawa H. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterol Motil. 2016;28(7):1027-1036.
Yang H, Zhao X, Tang S, Huang H, Zhao X. Probiotics reduce psychological stress in patients before laryngeal cancer surgery. Asia Pac J Clin Oncol. 2016;12(1):92-96.
Hallet v, Lecavalier L, Sukhodolsky DG, Cipriano N. Exploring the manifestations of anxiety in children with Autism Spectrum Disorders. J Autism Dev Disord. 2013;43(10):2341-2352.
Ashwood P1, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2011;25(1):40-45.
Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720-726.
Yoon JY, Cha JM, Hong SS, Kim HK, Kwak MS, Jeon JW, Shin HP. Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(35):601-608.
Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005;115(1):178-181.
Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 2014;13(2):227-239.
Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015;60(2):129-134.
Downloads
Publicado
Como Citar
Edição
Secção
Categorias
Licença
Direitos de Autor (c) 2022 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
